• CAS#1702967-37-0
  • NamePSMA 617(Vipivotide tetraxetan)
  • For reserach use only and not for human use!

Product Details

Good factory supply good PSMA 617(Vipivotide tetraxetan) 1702967-37-0

  • Molecular Formula:C49H71N9O16
  • Molecular Weight:1042.15
  • Boiling Point:1371.9±65.0 °C(Predicted) 
  • Density:1.322±0.06 g/cm3(Predicted) 

1702967-37-0 Relevant articles

Linker Modification Strategies to Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors

Bene?ová, Martina,Bauder-Wüst, Ulrike,Sch?fer, Martin,Klika, Karel D.,Mier, Walter,Haberkorn, Uwe,Kopka, Klaus,Eder, Matthias

, p. 1761 - 1775 (2016)

Since prostate-specific membrane antigen...

TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

-

Page/Page column 82; 83, (2021/01/29)

A compound of general formula (I): where...

METHOD OF TREATING PSMA-EXPRESSING CANCERS

-

Page/Page column 125-126, (2021/08/27)

The present invention relates to combina...

METHODS FOR PREPARING PSMA CONJUGATES

-

Paragraph 0261; 0266-0273, (2020/12/07)

This disclosure relates to processes for...

NOVEL RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER

-

Paragraph 0076; 0077, (2019/05/10)

This application relates to compounds of...

1702967-37-0 Process route

tri-tert-butyl (3S,10S,14S)-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-1-[(1r,4S)-4-({2-[4,7,10-tris(2-tert-butoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetamido}methyl)cyclohexyl]-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylate

tri-tert-butyl (3S,10S,14S)-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-1-[(1r,4S)-4-({2-[4,7,10-tris(2-tert-butoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetamido}methyl)cyclohexyl]-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylate

(3S,10S,14S)-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-1-[(1r,4S)-4-({2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetamido}methyl)cyclohexyl]-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid
1702967-37-0

(3S,10S,14S)-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-1-[(1r,4S)-4-({2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetamido}methyl)cyclohexyl]-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid

Conditions
Conditions Yield
With trifluoroacetic acid; In dichloromethane; at 18 - 25 ℃; Inert atmosphere;
64%
Fmoc-Lys(ivDde)-Wang resin

Fmoc-Lys(ivDde)-Wang resin

C<sub>14</sub>H<sub>23</sub>NO<sub>5</sub>

C14H23NO5

(1R,4R)-4-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclohexane-1-carboxylic acid
167690-53-1

(1R,4R)-4-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclohexane-1-carboxylic acid

1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid
137076-54-1

1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid

PMSA-617
1702967-37-0

PMSA-617

Conditions
Conditions Yield
Fmoc-Lys(ivDde)-Wang resin; C14H23NO5; With hydrazine; In N,N-dimethyl-formamide; Wang resin
(1r,4r)-4-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclohexane-1-carboxylic acid; 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid; In N,N-dimethyl-formamide; Wang resin
With trifluoroacetic acid; In N,N-dimethyl-formamide;
25%

1702967-37-0 Upstream products

  • 170908-81-3
    170908-81-3

    1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(N-hydroxysuccinimidyl ester)

  • 167690-53-1
    167690-53-1

    (1R,4R)-4-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclohexane-1-carboxylic acid

  • 137076-54-1
    137076-54-1

    1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid

  • 138774-94-4
    138774-94-4

    N-(9-fluorenylmethoxycarbonyl)-3-(β-naphthyl)-L-alanine

Inquiry
Product Name:
Company Name:
*Email:

Please enter your email

Tel:
*Content:

Please enter content

*Code:

Please enter content

The fields marked with*are required

Submit